The controversial therapeutic medication clenbuterol will soon face added restrictions in the Mid-Atlantic region, according to an Oct. 27 release from the Mid-Atlantic Strategic Plan to Reduce Equine Fatalities.
The controversial therapeutic medication clenbuterol will soon face added restrictions in the Mid-Atlantic region, according to an Oct. 27 release from the Mid-Atlantic Strategic Plan to Reduce Equine Fatalities.